ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Rigel Pharmaceuticals Inc

Rigel Pharmaceuticals Inc (RIGL)

23.06
1.28
(5.88%)
마감 03 3월 6:00AM
22.75
-0.31
(-1.34%)
시간외 거래: 9:55AM

행사 가격매수가매도가최근 가격중간 가격가격 변동가격 변동 %거래량미결제 약정최근 거래
13.007.5012.308.629.900.000.00 %03-
14.006.6011.306.408.950.000.00 %011-
15.005.8010.406.848.100.000.00 %02-
16.005.009.502.557.250.000.00 %05-
17.004.309.004.936.650.000.00 %020-
18.003.007.402.055.200.000.00 %07-
19.002.906.504.304.700.000.00 %0239-
20.002.755.703.704.2252.05124.24 %93801/03/2025
21.002.004.702.783.350.4921.40 %164401/03/2025
22.001.354.801.253.0750.000.00 %074-
23.001.152.402.001.7750.5840.85 %211601/03/2025
24.000.452.801.051.625-0.95-47.50 %1401/03/2025
25.000.451.751.001.100.1517.65 %2034301/03/2025
26.000.051.050.000.550.000.00 %00-
27.000.401.000.480.700.000.00 %016-
28.000.362.750.361.5550.000.00 %01-
29.000.251.750.251.000.000.00 %02-
30.000.250.650.300.450.0520.00 %93401/03/2025
31.004.301.754.303.0250.000.00 %01-
32.000.302.950.301.6250.000.00 %01-

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

행사 가격매수가매도가최근 가격중간 가격가격 변동가격 변동 %거래량미결제 약정최근 거래
13.001.904.801.903.350.000.00 %01-
14.002.204.802.203.500.000.00 %01-
15.001.212.551.211.880.000.00 %01-
16.001.502.951.502.2250.000.00 %021-
17.000.153.300.701.7250.000.00 %05-
18.000.303.401.101.850.000.00 %03-
19.000.552.300.551.425-0.20-26.67 %81101/03/2025
20.000.802.054.901.4250.000.00 %010-
21.000.952.402.451.6750.000.00 %023-
22.000.052.951.601.500.000.00 %0175-
23.001.402.501.701.950.000.00 %35001/03/2025
24.001.103.900.002.500.000.00 %00-
25.001.604.500.003.050.000.00 %00-
26.001.705.400.003.550.000.00 %00-
27.002.006.500.004.250.000.00 %00-
28.003.608.000.005.800.000.00 %00-
29.004.408.300.006.350.000.00 %00-
30.005.609.400.007.500.000.00 %00-
31.006.4010.500.008.450.000.00 %00-
32.007.1011.500.009.300.000.00 %00-

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
STAKSTAK Inc
US$ 3.97
(156.13%)
174.23k
ORGOOrganogenesis Holdings Inc
US$ 6.21
(102.28%)
59M
TRNRInteractive Strength Inc
US$ 2.57
(67.97%)
193.57M
PMAXPowell Max Ltd
US$ 0.511
(43.54%)
137.18M
ARBBARB IOT Group Ltd
US$ 0.6635
(38.23%)
59.08M
NVNINVNI Group Ltd
US$ 0.99
(-50.50%)
72.28M
SPGCSacks Parente Golf Inc
US$ 0.2085
(-48.65%)
57.4M
ADGMAdagio Medical Holdings Inc
US$ 0.8081
(-47.53%)
756.64k
PRAXPraxis Precision Medicines Inc
US$ 38.60
(-40.64%)
3.17M
SAGSAG Holdings Ltd
US$ 1.19
(-38.97%)
788.89k
NVDANVIDIA Corporation
US$ 124.92
(3.97%)
389.48M
TRNRInteractive Strength Inc
US$ 2.57
(67.97%)
193.57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 13.44
(7.78%)
154.46M
PMAXPowell Max Ltd
US$ 0.511
(43.54%)
137.18M
LCIDLucid Group Inc
US$ 2.22
(-0.45%)
136.17M

RIGL Discussion

게시물 보기
dcaf7 dcaf7 10 월 전
Titles of olutasidenib presentations at ASCO:
1. Safety and efficacy of olutasidenib treatment in elderly patients with relapsed/refractory mIDH1 acute myeloid leukemia.
2. Patients with relapsed/refractory mIDH1 AML who proceeded to transplant after olutasidenib treatment.
3. Olutasidenib for mutated IDH1 acute myeloid leukemia: Final five-year results from the phase 2 pivotal cohort.
👍️0
Monksdream Monksdream 10 월 전
RIGL under $2
👍️0
Monksdream Monksdream 11 월 전
RIGL under $2
👍️0
dcaf7 dcaf7 11 월 전
Just published, "Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (mIDH1) acute myeloid leukemia (AML)". The results of this phase 2 study support data from registrational cohort demonstrating that Olutasidenib works well in patients previously treated with venetoclax.
https://pubmed.ncbi.nlm.nih.gov/38538632/
👍️0
dcaf7 dcaf7 11 월 전
Good read on Olutasidenib
https://journals.lww.com/oncology-times/fulltext/2024/03000/olutasidenib_as_a_breakthrough_for_r_r_midh1_aml.25.aspx
Important further research: 1) studying whether olutasidenib can eliminate the stem cell fraction within each patient's IDH1-mutant AML; 2) characterization of synthetic lethality involving olutasidenib in IDH1-mutant AML.
👍️0
dcaf7 dcaf7 1 년 전
Rigel Pharmaceuticals Acquires U.S. Rights to GAVRETO®
FEBRUARY 22, 2024 7:50AM EST
GAVRETO® (pralsetinib) is an FDA approved targeted therapy for the treatment of RET fusion-positive metastatic non-small cell lung cancer and advanced or metastatic thyroid cancer
Acquisition of established U.S. marketed product further expands Rigel's portfolio and leverages Rigel's existing infrastructure in both the institutional and community settings
GAVRETO generated ~$28M in U.S. net product sales in 2023
👍️0
bme bme 2 년 전
Rigl should be VTGN (Today) one day.
👍️0
bme bme 2 년 전
Yeah. Should be good Q.
👍️0
TucsonPhil TucsonPhil 2 년 전
Hopefully, the inducement grants are being used to hire qualified talent, rather than pad the wallets of friends and relatives.
👍️0
bme bme 2 년 전
Better be good.
👍️0
bme bme 2 년 전
Ugly.
👍️0
The Night Stalker The Night Stalker 2 년 전
nice
👍️0
The Night Stalker The Night Stalker 2 년 전
nice
👍️0
The Night Stalker The Night Stalker 2 년 전
base
👍️0
bme bme 2 년 전
What a shoot! Amazing.
👍️0
bme bme 2 년 전
The next quarter fin should include the rev for TAVALISSE. "In April, Rigel's partner Kissei announced the launch of TAVALISSE in Japan for the treatment of chronic ITP."
1. What else should we expect as for the rev?
2. Result of phase 3 of Fostamatinib3 COVID 19?
3. Status of Fostamatinib-ACTIV4 COVID 19?
4. Partnered Programs?
👍️0
The Night Stalker The Night Stalker 2 년 전
nice fins
👍️0
The Night Stalker The Night Stalker 2 년 전
gem
👍️0
The Night Stalker The Night Stalker 2 년 전
gem
👍️0
The Night Stalker The Night Stalker 2 년 전
easy
👍️0
bme bme 2 년 전
Nice spike AH today.
👍️0
bme bme 2 년 전
Higher low higher low.... next leg is North.
👍️0
The Night Stalker The Night Stalker 2 년 전
https://www.barchart.com/stocks/quotes/RIGL/technical-chart?plot=BAR&volume=total&data=I:120&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=120&indicators=EXPMA(9);SMA(20);BBANDS(20,2);MACD(12,26,9)&sym=RIGL&grid=1&height=500&studyheight=100
👍️0
The Night Stalker The Night Stalker 2 년 전
https://www.barchart.com/stocks/quotes/RIGL/technical-chart?plot=BAR&volume=total&data=I:120&density=H120&pricesOn=1&asPctChange=0&logscale=0&im=120&indicators=EXPMA(9);SMA(20);BBANDS(20,2);MACD(12,26,9)&sym=RIGL&grid=1&height=500&studyheight=100
👍️0
bme bme 2 년 전
acting wild atm, but still healthy.
👍️0
The Night Stalker The Night Stalker 2 년 전
nice
👍️0
bme bme 2 년 전
Nice & Healthy.
👍️0
The Night Stalker The Night Stalker 2 년 전
quite the dip
👍️0
The Night Stalker The Night Stalker 2 년 전
ready
👍️0
The Night Stalker The Night Stalker 2 년 전
ready
👍️0
The Night Stalker The Night Stalker 2 년 전
red to green
👍️0
The Night Stalker The Night Stalker 2 년 전
red to green
👍️0
bme bme 2 년 전
Wonderful!
👍️0
The Night Stalker The Night Stalker 2 년 전
beauty
👍️0
The Night Stalker The Night Stalker 2 년 전
nice
👍️0
bme bme 2 년 전
Expect Q4 filing this week?
👍️0
bme bme 2 년 전
Be seeing that. Lot of 1.95 transactions so far
👍️0
TucsonPhil TucsonPhil 2 년 전
Revenue potential appears good. SP is slowly rising, and looks like it has been in accumulation for the past few weeks.
👍️0
bme bme 2 년 전
SP should be a lot higher since the Q4 revenue is more than double from last year...
👍️0
Welldoctor Welldoctor 2 년 전
Apparently insider buying reported on ST. Take it for what it’s worth.
👍️0
Welldoctor Welldoctor 2 년 전
RIGL news out
👍️0
bme bme 2 년 전
Looks like it will poke thru & bye bye 1 today.
👍️0
doesitreallymatter doesitreallymatter 2 년 전
Just like ABQQ. Right?
👍️0
subslover subslover 2 년 전
You are 1/2 way there!!!!
👍️0
KngmAz KngmAz 2 년 전
Wow - BOOM - we just went over a dollar - next step $10.00 - DON'T MISS OUT!!
👍️0
KngmAz KngmAz 2 년 전
This is a $10.00 per share stock in the very near future - EASILY!!
👍️0
Alaska40 Alaska40 2 년 전
I just bought in. Seems like a good run could come in the near future.
👍️0
subslover subslover 2 년 전
Consolidating nicely on Continuation from last week!
👍️0
bcapps66 bcapps66 2 년 전
LOL!
👍️0
THEMASTERS_SON THEMASTERS_SON 2 년 전
GIVE ME MY $2DOLLAS…YA BUM
👍️0

최근 히스토리

Delayed Upgrade Clock